Skip to content

EXCLI journal

ISSN 1611-2156

2 papers in the library · publishing 2022-2026

Papers

Sort Most recent Most cited

Metabolic profiling reveals potential biomarkers and underlying signaling pathways involved in mindfulness-based cognitive therapy-improved adolescent depression symptoms.

EXCLI journal 2026 Chun-Hua Xu, Bi-Lan Zhang, Chun-Lan Guan et al.

Mindfulness-based cognitive therapy (MBCT) demonstrates significant efficacy in improving depressive symptoms and modulating metabolic profiles. However, the specific metabolite biomarkers and metabolic pathways underlying MBCT's therapeutic effects in adolescent depression remain unclear. This study aims to identify potential metabolite biomarkers and metabolic regulation pathways associated...

DOI: 10.17179/excli2025-8918 (opens in new tab) Full text (opens in new tab) Adolescent depression Biomarker Differentially abundant metabolite Metabolic regulation pathway +2

Use of intranasal esketamine in a girl with treatment-resistant depression and autism spectrum disorders: a case report.

EXCLI journal 2022 Miriam Olivola, Vincenzo Arienti, Nicola Bassetti et al.

Major depression is a common comorbidity in autism spectrum disorder (ASD), often difficult to identify and to treat. Autistic subjects are more at risk for suicidal thoughts and behaviors compared to typically developing peers. Unfortunately, ASD individuals are more frequently treatment-resistant and often show side-effects which reduce efficacy. Intranasal esketamine has been recently...